
Vanda Pharmaceuticals Inc. | A Global Biopharmaceutical Company
Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients.
Vanda Pharmaceuticals Inc. (VNDA) - Yahoo Finance
Find the latest Vanda Pharmaceuticals Inc. (VNDA) stock quote, history, news and other vital information to help you with your stock trading and investing.
VNDA Stock Price | Vanda Pharmaceuticals Inc. Stock Quote (U.S.: …
5 days ago · Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, …
Vanda Pharmaceuticals (VNDA) Stock Price, News & Analysis
4 days ago · Vanda Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for central nervous system (CNS) …
Vanda Announces Submission of Biologics License ... - Morningstar
1 day ago · Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the …
Vanda touts 'landmark' win over FDA in yearslong dispute
Aug 18, 2025 · With a win in a D.C. appeals court, Vanda Pharmaceuticals has earned a point over the FDA in the yearslong face-off between the drugmaker and the drug regulator.
Vanda Pharmaceuticals (VNDA) Stock Price & Overview
3 days ago · A detailed overview of Vanda Pharmaceuticals Inc. (VNDA) stock, including real-time price, chart, key statistics, news, and more.
Vanda Pharmaceuticals Inc. (VNDA) Stock Price & News - Google
Get the latest Vanda Pharmaceuticals Inc. (VNDA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Vanda jumps as FDA lifts tradipitant partial clinical hold
Dec 4, 2025 · Vanda Pharmaceuticals (VNDA) has surged ~7% in after-hours trading Thursday after the US FDA lifted its partial clinical hold on tradipitant for motion sickness. The drugmaker said that the …
Vanda Pharmaceuticals (VNDA) Submits BLA to FDA for New Psoriasi
1 day ago · Key Takeaways: Vanda Pharmaceuticals (VNDA) has submitted a Biologics License Application for imsidolimab, targeting generalized pustular psoriasis (GPP).